These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 27150470)

  • 1. Stability of β-Lapachone upon Exposure to Various Stress Conditions: Resultant Efficacy and Cytotoxicity.
    Kim KH; Park SH; Adhikary P; Cho JH; Kang NG; Jeong SH
    Chem Pharm Bull (Tokyo); 2016; 64(5):381-9. PubMed ID: 27150470
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Light effect on the stability of β-lapachone in solution: pathways and kinetics of degradation.
    Cunha-Filho MS; Estévez-Braun A; Pérez-Sacau E; Echezarreta-López MM; Martínez-Pacheco R; Landín M
    J Pharm Pharmacol; 2011 Sep; 63(9):1156-60. PubMed ID: 21827487
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preclinical genotoxicology of nor-β-lapachone in human cultured lymphocytes and Chinese hamster lung fibroblasts.
    Cavalcanti BC; Barros FW; Cabral IO; Ferreira JR; Magalhães HI; Júnior HV; da Silva Júnior EN; de Abreu FC; Costa CO; Goulart MO; Moraes MO; Pessoa C
    Chem Res Toxicol; 2011 Sep; 24(9):1560-74. PubMed ID: 21830773
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of storage conditions on the stability of β-lapachone in solid state and in solution.
    Cunha-Filho MS; Martínez-Pacheco R; Landin M
    J Pharm Pharmacol; 2013 Jun; 65(6):798-806. PubMed ID: 23647673
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DNA damage and cytotoxicity induced by beta-lapachone: relation to poly(ADP-ribose) polymerase inhibition.
    Vanni A; Fiore M; De Salvia R; Cundari E; Ricordy R; Ceccarelli R; Degrassi F
    Mutat Res; 1998 Jun; 401(1-2):55-63. PubMed ID: 9639674
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and potent antitumor activity of new arylamino derivatives of nor-beta-lapachone and nor-alpha-lapachone.
    da Silva Júnior EN; de Souza MC; Pinto AV; Pinto Mdo C; Goulart MO; Barros FW; Pessoa C; Costa-Lotufo LV; Montenegro RC; de Moraes MO; Ferreira VF
    Bioorg Med Chem; 2007 Nov; 15(22):7035-41. PubMed ID: 17827021
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of beta-lapachone prodrugs for therapy against human cancer cells with elevated NAD(P)H:quinone oxidoreductase 1 levels.
    Reinicke KE; Bey EA; Bentle MS; Pink JJ; Ingalls ST; Hoppel CL; Misico RI; Arzac GM; Burton G; Bornmann WG; Sutton D; Gao J; Boothman DA
    Clin Cancer Res; 2005 Apr; 11(8):3055-64. PubMed ID: 15837761
    [TBL] [Abstract][Full Text] [Related]  

  • 8. β-Lapachone Regulates the Transforming Growth Factor-β-Smad Signaling Pathway Associated with Collagen Biosynthesis in Human Dermal Fibroblasts.
    Park SH; Jeong SH; Kim SW
    Biol Pharm Bull; 2016; 39(4):524-31. PubMed ID: 26804133
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis of new 9-hydroxy-α- and 7-hydroxy-β-pyran naphthoquinones and cytotoxicity against cancer cell lines.
    da Rocha DR; de Souza AC; Resende JA; Santos WC; dos Santos EA; Pessoa C; de Moraes MO; Costa-Lotufo LV; Montenegro RC; Ferreira VF
    Org Biomol Chem; 2011 Jun; 9(11):4315-22. PubMed ID: 21487631
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comprehensive Insight into Chemical Stability of Important Antidiabetic Drug Vildagliptin Using Chromatography (LC-UV and UHPLC-DAD-MS) and Spectroscopy (Mid-IR and NIR with PCA).
    Gumieniczek A; Berecka-Rycerz A; Fornal E; Żyżyńska-Granica B; Granica S
    Molecules; 2021 Sep; 26(18):. PubMed ID: 34577104
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro and in vivo wound healing-promoting activities of beta-lapachone.
    Kung HN; Yang MJ; Chang CF; Chau YP; Lu KS
    Am J Physiol Cell Physiol; 2008 Oct; 295(4):C931-43. PubMed ID: 18650264
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 3-arylamino and 3-alkoxy-nor-beta-lapachone derivatives: synthesis and cytotoxicity against cancer cell lines.
    da Silva EN; de Deus CF; Cavalcanti BC; Pessoa C; Costa-Lotufo LV; Montenegro RC; de Moraes MO; Pinto Mdo C; de Simone CA; Ferreira VF; Goulart MO; Andrade CK; Pinto AV
    J Med Chem; 2010 Jan; 53(1):504-8. PubMed ID: 19947600
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protective microencapsulation of β-lapachone using porous glass membrane technique based on experimental optimisation.
    Kim KH; Le TH; Oh HK; Heo B; Moon J; Shin S; Jeong SH
    J Microencapsul; 2017 Sep; 34(6):545-559. PubMed ID: 28805467
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inactivation of β-Lapachone Cytotoxicity by Filamentous Fungi that Mimic the Human Blood Metabolism.
    Paludo CR; da Silva-Junior EA; de Oliveira Silva E; Vessecchi R; Peporine Lopes N; Tallarico Pupo M; da Silva Emery F; Dos Santos Gonçalves N; Alves Dos Santos R; Jacometti Cardoso Furtado NA
    Eur J Drug Metab Pharmacokinet; 2017 Apr; 42(2):213-220. PubMed ID: 27059844
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Yeast cytotoxic sensitivity to the antitumour agent β-lapachone depends mainly on oxidative stress and is largely independent of microtubule- or topoisomerase-mediated DNA damage.
    Ramos-Pérez C; Lorenzo-Castrillejo I; Quevedo O; García-Luis J; Matos-Perdomo E; Medina-Coello C; Estévez-Braun A; Machín F
    Biochem Pharmacol; 2014 Nov; 92(2):206-19. PubMed ID: 25241291
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chemical stability and in vitro and clinical efficacy of a novel hybrid retinoid derivative, bis-retinamido methylpentane.
    Kim KH; Lim DG; Lim JY; Kim NA; Park SH; Cho JH; Shin BS; Jeong SH
    Int J Pharm; 2015 Nov; 495(1):93-105. PubMed ID: 26325317
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Electronic structure and gas-phase chemistry of protonated α- and β-quinonoid compounds: a mass spectrometry and computational study.
    Vessecchi R; Emery FS; Lopes NP; Galembeck SE
    Rapid Commun Mass Spectrom; 2013 Apr; 27(7):816-24. PubMed ID: 23495028
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis of biologically active (-)-dehydroiso-β-lapachone and the determination of its absolute configuration.
    Kimachi T; Torii E; Kobayashi Y; Doe M; Ju-ichi M
    Chem Pharm Bull (Tokyo); 2011; 59(6):753-6. PubMed ID: 21628913
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oxyrane derivative of alpha-lapachone is potent growth inhibitor of Trypanosoma cruzi epimastigote forms.
    Jorqueira A; Gouvêa RM; Ferreira VF; da Silva MN; de Souza MC; Zuma AA; Cavalcanti DF; Araújo HP; Santos DO; Bourguignon SC
    Parasitol Res; 2006 Sep; 99(4):429-33. PubMed ID: 16596415
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intratumoral delivery of beta-lapachone via polymer implants for prostate cancer therapy.
    Dong Y; Chin SF; Blanco E; Bey EA; Kabbani W; Xie XJ; Bornmann WG; Boothman DA; Gao J
    Clin Cancer Res; 2009 Jan; 15(1):131-9. PubMed ID: 19118040
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.